Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Wondering which is better: cash back or points credit card? Explore the pros and cons to choose the right card for your needs.
27,103 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
Dell Technologies rode a wave of AI server demand to a $33.4 billion quarterly revenue, beating expectations and lift...
With $1,000 in hand, you can explore high-growth artificial intelligence moonshots. This guide breaks down two potent...
Understanding James River (JRVR) earnings means decoding insurance results, investment income, and risk management. T...
LifeStance Health Group stunned the market with a beat-and-raise quarter, sending its stock up roughly 20%. This deep...
From boxed software on shelves to cloud-based subscriptions, software pricing has evolved dramatically. This guide br...
Is Nebius the nebius next amazon? This article digs into Nebius's model, how it stacks up to Amazon, and what it woul...
AST SpaceMobile has surged, leaving investors asking whether spacemobile buy, sell, hold makes sense now. This articl...
AMD posts robust data-center growth and free cash flow gains, while Intel sticks to its turnaround plan with heavy fo...
Bitcoin rebounded back toward $65,000 after a volatile weekend tied to regional tensions. ETF flows returning to cent...
XRP’s Bollinger Bands have tightened once more, reviving chatter of a possible breakout. Here’s what traders are watc...
Memory names bounced Thursday, with SanDisk up 9%, Western Digital rising 5%, and Micron gaining 3% as AI-driven stor...